investigated the effect of high-dose vitamin D3 treatment on beta-cell function, insulin sensitivity, and glucose tolerance in subjects with prediabetes or diet-treated type 2 diabetes adults (n = 43, BMI 28.6) randomized to 30,000 IU of cholecalciferol or placebo drops weekly for 8 weeks. This evidence concerns the gene INS and prediabetes syndrome.